Mar.15 — Noubar Afeyan, co-founder of Moderna Inc. and CEO of Flagship Pioneering Inc., discusses the remaining challenges in the Covid-19 vaccination efforts and the progress in creating shots for children. He also says speculation about the efficacy of the AstraZeneca PLC doses are not helpful and there needs to be trust in authorities who are working hard to deliver solutions. Afeyan speaks to Emily Chang on “Bloomberg Technology.”
source
Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.
This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.